Colgate-Palmolive Posts 3Q EPS of 94 Cents
CL sits 26% above its 52-week low of $74.545.
Summary
Colgate-Palmolive reported third-quarter EPS of 94 cents, with adjusted EPS of 97 cents, on net income of $751 million and sales of $5.37 billion, as organic sales growth rose 3.6%. GAAP gross profit margin rose 80 bps to 60.2% and Base Business gross margin rose 90 bps to 60.3%. The company narrowed its 2026 sales growth view to 4%-5% from 2%-6%, and now sees 2026 adjusted EPS up 5%-7%, having previously seen it up mid-single digits. Context matters here: the company beat Q2 estimates and raised its full-year outlook in late July while expanding a restructuring program now expected to cost up to $550 million, so the bar was set high. The stock trades near $94 with a large-cap base, meaning a single quarterly print moves the shares only if it diverges sharply from consensus.
Updated with an SEC 8-K filing · What changed
Updates
· SEC 8-K — Colgate's Q3 GAAP gross profit margin rose 80 bps to 60.2% and Base Business gross margin rose 90 bps to 60.3%; full-year net sales guidance narrowed to up 4%-5%.
At the time of this announcement, CL was trading at $94.00 on NYSE in the Manufacturing sector, with a market capitalization of approximately $74.3B. The 52-week trading range was $74.55 to $99.33. This news item was assessed with neutral market sentiment and an importance score of 7 out of 10. Source: Dow Jones Newswires.